Lifetime Brands: GLP-1, Weight Loss Livestream Event

Lifetime Brands, Inc. (NasdaqGS: LCUT), a leading global designer, developer, and marketer of branded consumer products used in the home, is set to host a complimentary livestream event focused on GLP-1 agonists and weight loss on September 25. The event, titled "GLP-1 and Weight Loss Drugs: The Future of Obesity Management," will feature the company's Chief Science Officer and a panel of experts in the field.

The event aims to address the role of GLP-1 agonists in weight loss and management, presenting the latest research and clinical trials on these drugs. The panelists will also discuss potential side effects and risks associated with GLP-1 agonists, ensuring a comprehensive and well-rounded discussion.

The focus on GLP-1 and weight loss drugs aligns with current market trends and investor interests, as the global weight loss drugs market is expected to reach $13.4 billion by 2027, growing at a CAGR of 6.6% during the forecast period. The complimentary nature of the event will also increase its accessibility and potential reach to a wider audience of investors.